Bavarian Nordic to supply smallpox vaccines to three European countries
The company hopes its newly built fill and finish facility will assume commercial manufacturing this year
Vaccines specialist Bavarian Nordic A/S has secured contracts with a combined value of EUR 11 million with three European governments for the supply of Imvanex smallpox vaccine.
Imvanex, the only EU-approved non-replicating smallpox vaccine, is manufactured at Bavarian Nordic’s Denmark-based commercial-scale facility, which has been producing the bulk smallpox vaccine for more than a decade.
Although the final drug product manufacturing has taken place with a contract manufacturer, Bavarian Nordic will soon commission its own fill and finish facility as part of the company’s expansion of the facility to become a center of excellence for live viral vaccine manufacturing.
The construction of the fill and finish facility has been completed in less than 2 years, and pending final validation and qualification, the facility will assume commercial manufacturing in 2021 with liquid-frozen Jynneos (US trade name for the smallpox vaccine) as the first product on the line.
The facility also houses lyophilization capabilities, and a freeze-dried version of the smallpox vaccine is currently in the final stages of development, anticipated ready for manufacturing in 2022.
In addition, construction work is currently ongoing for expansion of the facility to allow for simultaneous bulk manufacturing of multiple products. This investment will enable Bavarian Nordic to transfer the manufacturing of the two vaccines, Rabipur/RabAvert (against rabies) and Encepur (against tick-borne encephalitis) according to the planned schedule after having acquired the vaccines from GlaxoSmithKline (GSK) in 2019.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance